Vaginal dryness affects up to 50% of postmenopausal women, yet surveys consistently show that most suffer in silence — too embarrassed to bring it up, or unaware that effective treatments exist. Unlike hot flashes, which often resolve on their own over time, vaginal dryness and atrophy tend to worsen with age without treatment.

The good news: there are highly effective treatments available, from simple over-the-counter options to prescription therapies with decades of evidence behind them. And with telehealth, getting appropriate care has never been easier or more private.

What Is Vaginal Atrophy?

Vaginal atrophy (also called atrophic vaginitis) refers to the thinning, drying, and inflammation of vaginal tissue that occurs when estrogen levels decline. Many clinicians now use the term genitourinary syndrome of menopause (GSM), which better captures the full range of affected tissues — including the vulva, urethra, and bladder.

Estrogen is essential for maintaining vaginal health. It supports:

  • Thickness and elasticity of vaginal tissue
  • Production of natural lubrication
  • Acidic vaginal pH that protects against infection
  • Healthy vaginal microbiome
  • Blood flow to vaginal and vulvar tissue

When estrogen drops — as it does in menopause, perimenopause, or other estrogen-deficient states — all of these mechanisms are compromised.

Causes of Vaginal Dryness

While menopause is the most common cause, vaginal dryness can occur at any age due to estrogen deficiency or other factors:

Hormonal Causes

  • Menopause and perimenopause — declining ovarian estrogen production
  • Surgical menopause — removal of both ovaries causes an abrupt and complete drop in estrogen
  • Postpartum and breastfeeding — prolactin suppresses estrogen; many nursing mothers experience significant vaginal dryness
  • Hormonal contraceptives — some women experience reduced vaginal lubrication on low-estrogen or progestin-only contraceptives
  • Cancer treatments — chemotherapy and radiation can cause premature ovarian insufficiency; certain breast cancer treatments (aromatase inhibitors, tamoxifen) directly lower estrogen
  • Premature ovarian insufficiency (POI) — loss of normal ovarian function before age 40
  • Hypothalamic amenorrhea — suppressed hormone production due to extreme exercise, low body weight, or chronic stress

Non-Hormonal Causes

  • Sjögren's syndrome — autoimmune condition that affects moisture-producing glands
  • Certain medications — antihistamines, antidepressants (SSRIs/SNRIs), some antihypertensives
  • Harsh soaps or personal care products — irritate sensitive vulvar tissue
  • Insufficient arousal — inadequate foreplay or arousal reduces natural lubrication regardless of hormonal status
  • Smoking — impairs blood flow and worsens atrophic changes

Symptoms of Vaginal Dryness and GSM

The symptoms of genitourinary syndrome of menopause extend beyond vaginal dryness alone:

  • Vaginal dryness, itching, or burning
  • Discomfort or pain during sexual intercourse (dyspareunia)
  • Vaginal discharge or odor changes
  • Light bleeding after intercourse (from fragile tissue)
  • Recurrent vaginal infections
  • Urinary urgency or frequency
  • Recurrent urinary tract infections (UTIs)
  • Stress urinary incontinence
  • Painful urination (dysuria)

Many women aren't aware that their recurrent UTIs or urinary urgency may be related to vaginal atrophy — both respond to estrogen treatment.

Over-the-Counter Options

For mild to moderate symptoms, or while awaiting a prescription evaluation, several OTC options can provide meaningful relief:

Vaginal Moisturizers

Unlike lubricants, vaginal moisturizers are used regularly (every 2–3 days, not just during sex) to maintain baseline hydration. They work by attracting water to vaginal tissue. Look for products that are:

  • Hypo-allergenic and free of fragrances, parabens, and glycerin
  • Formulated with hyaluronic acid or polycarbophil (proven moisturizing agents)
  • Specifically designed for vaginal use

Examples include Replens and products containing hyaluronic acid. Regular use can meaningfully improve comfort, though they don't reverse the underlying tissue changes caused by estrogen deficiency.

Vaginal Lubricants

Lubricants reduce friction during intercourse but provide no lasting moisturizing effect. Water-based lubricants are compatible with condoms and most sex toys. Silicone-based lubricants last longer. Avoid lubricants with fragrances, flavors, warming agents, or high osmolality (these can damage vaginal tissue).

Vitamin E Suppositories

Some evidence supports the use of vaginal vitamin E for mild dryness. These are generally well tolerated but are less effective than prescription estrogen for moderate-severe atrophy.

Prescription Treatment Options

For women with moderate to severe GSM, or those who don't find adequate relief from OTC options, prescription therapies are often highly effective. The cornerstone treatments are local (vaginal) estrogen and systemic hormone replacement therapy.

Local (Vaginal) Estrogen

Local estrogen therapies deliver estrogen directly to vaginal tissue at very low doses, with minimal systemic absorption. They are considered safe for most women, including many who cannot use systemic hormone therapy. Options include:

  • Vaginal estrogen cream (Estrace, generic estradiol cream) — applied with an applicator; flexible dosing; well studied
  • Vaginal estrogen tablets (Vagifem, Yuvafem) — small insertable tablets; convenient and mess-free
  • Vaginal estrogen ring (Estring) — a small ring inserted by a provider or patient that slowly releases estrogen for 90 days; low-maintenance option
  • Vaginal estrogen suppositories (Imvexxy) — soft gel suppositories with very low estradiol dose; FDA-approved for moderate-to-severe dyspareunia from GSM
  • Prasterone/DHEA vaginal insert (Intrarosa) — a non-estrogen option; DHEA is converted to both estrogen and testosterone locally in vaginal tissue; FDA-approved for dyspareunia

Important note for women with hormone-sensitive breast cancer history: The use of vaginal estrogen in women on aromatase inhibitors or with hormone receptor-positive breast cancer history requires careful discussion with both an oncologist and gynecologist. Emerging data suggests very low-dose local estrogen may be acceptable for some patients, but this decision should be made on a case-by-case basis.

Ospemifene (Osphena)

Ospemifene is an oral selective estrogen receptor modulator (SERM) FDA-approved for moderate-to-severe dyspareunia and dryness from GSM. It acts like estrogen on vaginal tissue but not on breast tissue — making it an option for women who prefer or require non-vaginal therapy. It is not recommended for women with a history of certain hormone-sensitive cancers.

Systemic Hormone Replacement Therapy (HRT)

Systemic HRT — estrogen taken orally, transdermally (patch, gel, spray), or via implant — treats vaginal atrophy as part of its broader menopausal symptom relief effects. It is the most effective option for women with multiple menopausal symptoms (hot flashes, sleep disruption, mood changes, AND vaginal dryness).

Women with an intact uterus require progesterone alongside systemic estrogen to protect the uterine lining from overstimulation. Transdermal estrogen is generally preferred for its lower risk of blood clots compared to oral estrogen.

The decision to use systemic HRT involves a risk-benefit discussion with your provider considering your age, time since menopause, personal health history, and symptoms.

Lifestyle Factors That Help

Several lifestyle practices support vaginal health and complement medical treatment:

  • Regular sexual activity — increases blood flow to vaginal tissue and helps maintain tissue integrity
  • Avoid irritants — fragrant soaps, douches, scented pads, and tight synthetic underwear can worsen symptoms
  • Pelvic floor physical therapy — highly effective for women with pain during intercourse related to pelvic floor dysfunction
  • Quit smoking — smoking worsens blood flow to vaginal tissue and accelerates atrophic changes
  • Stay hydrated — adequate hydration supports overall mucosal health
  • Omega-3 fatty acids — support anti-inflammatory processes and may benefit mucosal tissue health

When to Seek Medical Help

You should seek evaluation for vaginal dryness when:

  • OTC options haven't provided adequate relief after 4–6 weeks of regular use
  • Symptoms are causing significant discomfort or affecting your sexual relationship and quality of life
  • You're experiencing recurrent UTIs or urinary symptoms
  • You notice bleeding after intercourse or unusual discharge
  • You're experiencing GSM symptoms before or shortly after menopause and want to prevent worsening

Questions to Ask Your Provider

Coming to your appointment prepared helps you get the most out of your visit. Consider asking:

  • Is local estrogen appropriate for me given my health history?
  • Which formulation would best fit my lifestyle and preferences?
  • Do I need a progestogen if I'm only using vaginal estrogen?
  • Are my urinary symptoms related to GSM, and would estrogen treatment help?
  • Should I be evaluated for pelvic floor dysfunction?
  • Are there any concerns given my personal cancer history or family history?

How Telehealth Can Help

Vaginal dryness is one of the most common conditions for which women delay seeking care — often due to embarrassment or the perception that it's just something to "accept" as part of aging. Telehealth removes these barriers completely.

A licensed telehealth provider can:

  • Take a thorough history and evaluate your symptoms
  • Prescribe local estrogen therapy, ospemifene, or systemic HRT if appropriate
  • Order relevant labs if needed
  • Provide ongoing monitoring and dose adjustment
  • Refer for pelvic floor PT or in-person evaluation when indicated

There's no reason to continue suffering from a condition that responds well to safe, evidence-based treatment.